Management of malaria with acute renal failure by Wilairatana, Polrat et al.
African Journal of Nephrology (1999) 3:67-72
Original Article
AJfN
Management of malaria with acute renal failure
Polrat Wilairatana', Sornchai Looareesuwan *, Guy H Neild **
Department of Clinical Tropical Medicine and Bangkok Hospital for Tropical Diseases,Faculty of Tropical Medicine,
Mahidol University, 420/6 Rajavithi Road, Bangkok 10400,Thailand * - Institute of Urology and Nephrology, University
College London **
Introduction
In parts of the world, such as Africa, where
Plasmodium falciparum is endemic and its
transmission is stable, severe malaria affects mainly
children. Cerebral malaria and severe anaemia are
common but mutii-organ failure involving the kidneys
or liver is very rare. Surviving children develop
immunity and thus as adults rarely develop severe
disease III. In contrast, in other tropical countries
where transmission of P. [alciparum is unstable and
the risk of infection low, severe malaria can occur at
any age. Severe malaria is defined as parasitacrnia
greater than 5'* or vital organ dysfunction. Acute
renal failure (ARF) is a common complication of
severe falciparum malaria in non-immune individuals.
At the Bangkok Ilospital for Tropical Disease, 5,210
patients with falciparummalaria were admitted during
the period 1991-1997 of whom I 12 pat icnis (2.129r)
had ARF. In a recent study of 560 cases of severe
adult malaria in Vietnam, 2W'!(l of patients had renal
failure on admission and 419r at some stage, with
140/, overall requiring dialysis 121.Overall, however,
ARF is not a C01111110ncomplication of malaria.
During the Vietnam war, the reported incidence was
19 cases in 3,]00 malarial admissions in 1965/6 and 8
of200J admissions in 19661713,41·
('orrl"!Wfldl'I/('I' (/ful (~I.II)ril/f requests to: Dr. (iII Neild. Middlc ...cx l lovpuul.
Mortimer Sr., London WIN 81\1\. United Kingdom.
Acute renal failure
Immediate management
ARP is managed simultaneously with the treatment
of malaria and the treatment of other complications
(see table I). Several important decisions must be
taken when the patient is admitted:
• Is the malaria complicated or not?
• What is the best treatment for malaria?
• What is the immune status of the patient?
• General standard management.
• ldenti fication and management of
cornpl ications.
Clinicalfeatures
Diagnosis: ARP is defined as either 15]:
• Plasma creatinine greater than 270 IJ mol/l
(> 3 mg/dl) even after fluid repletion.
• Oliguria «400 ml per day).
Presentation: With severe malaria, 50% of patients
will have a raised urea and creatinine at the time of
admission. This reflects the dehydration and
hypovolacrnia that occurs with sweating, vomiting
and diarrhoea. With fluid replacement the plasma
concentrations of urea and creatinine usually return
to the normal range. Patients are ex trernel y catabolic
(hypercarabolic) which will cause a
disproportionate rise in the blood urea to creatinine
ratio. This will be further exaggerated if the patient
is dehydrated and has pre-renal failure with low
urine volumes.
ARP usually develops simultaneously with other
complications (see table I), but can develop later
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Table 1. Complication of malaria
when patients are already oedematous and sick with other complications.
Manifesto/ion Definition
Cerebral
• Impaired consciousness
• Repeated convulsions
Anaemia
Acute renal failure
Pulmonary oedema
Hypoglycaemia
Shock
Spontaneous bleeding
Acidaernia
Macroscopic haemoglobinuria
Severe weakness/prostration
Hyperparasitaernia
Jaundice
Hyperpyrexia
Coma for> 30 minutes following convulsion and if no other explanation .
> 2 per 24 hours in the absence of hyperpyrexia .
Haernatoerit < 15%, haemoglobin < 5 g/dl.
< 400 ml/day adult or < 12 ml/kg/day child, Creatinine> 270 pnol/I (> 3 mg/dl).
Low central venous pressure and pulmonary oedema in the absence of fluid overload.
Glucose < 2.2 rnmol/l « 40 mg/dl).
Systolic BP < 50 mmHg children (1-5 yrs) or < 70 mmHg in adult, or core-skin difference> 10°C.
or disseminated intravascular coagulation (DlC).
Arterial pH < 7.25. venous bicarbonate < 15 mrnol/i.
Haemoglobinuria. without G6PD-delïciency.
> I 00 OOO/ul parasites/rl., or> 5%, >500 ODD/ui - high mortality.
Hyperbilirubinaemia> 50 pnol/l (> 3 mg/dl).
Rectal temperature> 40°C.
Clinical course: Oliguria usually occurs towards the
end of the first week and lasts for one week. It is
prolonged in elderly patients with underlying
renovascular disease. Acute renal failure is commonly
complicated by a septic shock syndrome and
sometime.s by septicaemia. When ARF develops after
the acute phase it is more likely to be non-oliguric and
dialysis not required [I].
There are many WHO criteria for severe
complications of acute malaria [5 J and there are
differences between the features of severe malaria in
adults and in children (table 2). The prognostic
factors listed in table 3 reflect vital organ
dysfunction and magnitude of the parasite burden.
They are not absolute, and in fatal cases several
factors usually coexist.
Table 2. Relative incidence of severe falciparum malaria complications
Non-pregnant adults Pregnant women Children
Anemia + ++ +++
Convulsions + + +++
Hypoglycemia + +++ +++
Jaundice +++ +++ +
Renal failure +++ +++
Pulmonary edema ++ +++ +
From White NJ. Malaria. In: Cook CG (ed), Manson's Tropical Diseases. 12 edn. WB Saunders, London. 1996, pp 1144.
Table j. Features indicating a poor prognosis in severe malaria
Clinical indicators:
Age under 3 years
Deep coma
Witnessed or reported convulsions
Absent corneal renexes
Decerebrate rigidity
Clinical signs of organ dysfunction
(eg. renal failure, pulmonary edema)
Retinal hemorrhages
Shock
Laboratory indicators:
Hyperparasitcmia (>IOO,OOO/ul or>5o/r)
Peripheral shizorucrnia
Peripheral leukocytosis (> 12,OOO/ul)
Packed cell volume less than 20o/r
Hemoglobin <7.0 gldl
Blood glucose les, than 2.2 rnmol/l «40 mg/dl)
Low CSF glucose
Blood urea> 21 11111101/1(>60 rng/dl)
Creatinine more than 270 pnol/I (>3.0 rug/dl)
High CSF lactic acid (>6 mmol/l)
Raised venous lactic acid (>6 111mol/1)
More than 3-fold elevation of serUJ11liver enzymes (amino-transferases)
Derived from White NJ. Malaria in: Cook CG (ed). Manson's Tropical Diseases. 12 edn. WB Saunders, London, 1996, pp 1117 (1'<:1'20)
Treatment: Patients should be evaluated carefully for
hydration status. If patients have a reduced urine
output, they may be either dehydrated and
hypovolaernic (pre-renal cause) or have established
acute renal failure with acute tubular necrosis
(ATN). fn hypovolaemic patients, rehydration
should be attempted orally, or intravenously when
necessary (see figure J). Intravenous fluids must be
given cautiously in case pulmonary oedema develops.
Central venous pressure should be monitored and kept
below 5 cm H20.
OLIGURIA
i
REPLACENtENT
THERAPY
/~
RESPONSE.. NO RESPONSE..
RESPONSE.. NO RESPONSE..
RESPONSE, NO RESPONSE
RESPONSE..
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We recommend that gastric acidity is reduced by
proton pump inhibitors or histamine (Hl) receptor
antagonists. Early enteric feeding should be
encouraged.
ACT/ON
i. v. Saline - restore circulating volume,
but maintain CVP 1-5 cm H20
f---- Frusemide 40 mg iv.
30 mins
f---- Frusemide 160 mg iv.
30 mins
f---- Frusemide 500 mg iv.
30 mins
NO RESPONSE..
30 mins
f-- Dopamine (2.5-5.0 j.ig/kg/min)
MA.INTENANCE THERAPY
Fig. I.Guideline, 10 lluid manugcmcru
Antintolarial therapy: Parenteral antimalarial drugs
should be given in severe malaria and quinine remains
the drug or first choice in most parts of the world. It
must be diluted and given slowly. 20 mg/kg of the
dihydrochloridc salt should be given over 4 hours as a
loading dose, followed by 10 mg/kg infused over 2-8
hours every 8 hours for 7 days or until alternative
drugs can be taken orally 161. After 3 days the dose of
quinine should be reduced by 30-50 l!f in patients
with reduced renal clearance. Quinine can cause
hypcr-insulinacrnia and hypoglycacrnia.
Artemisinin derivatives are potent antimalarial drugs
and are increasingly used in areas of chloroquine
resistance, such as SE Asia 1271. They arc not
licensed for use yet in the UK.
DIALYSIS
Complications and their management (see table I)
Respiratory
Pulmonary oedema can be due to iatrogenic
intravenous fluid overload or to ARDS (adult
respiratory distress syndrome) caused by low
pressure pulmonary oedema [7]. It is a grave
complication of severe malaria with high mortality
(over 50%) and can even appear several days after
therapy has started, at a time when the patient's
general condition is improving and the peripheral
parasitemia is diminishing. It is more common in
association with renal failure, hyperparasitemia,
hypoglycaemia and metabolic acidosis. Malaria in
pregnancy usually has a high risk of pulmonary
oedema, particularly after delivery.
70
Changes in respiration can be a warning sign of
hypoglycaemia, metabolic acidosis, pneumonia,
pulmonary oedema, or as a result of high fever alone.
Cerebral malaria
Cerebral malaria is defined as unrousable coma in a
patient with asexual forms of P. falciparum in the
peripheral blood and no other identifiable cause of
unconsciousness [8].
In the tropics the list of differential diagnoses is large,
but in practice obtaining an accurate history,
completing a detailed clinical examination and
performing a lumbar puncture excludes most of the
alternative diagnoses (with the possible exception of
viral encephalitis which may have to wait
demonstration of virus or viral speci fic IgM in the
CSF). It should also be noted that bacterial meningitis
or other severe bacterial infections can co-exist with
cerebral malaria.
Hypoglycaemia
Frequent monitoring of blood glucose is essential.
Hypoglycaemia should be suspected in any patient
whose consciousness is deteriorating, who develops
convulsions or who has changed respiratory patterns.
Hypoglycaemia should be reversed by slow
intravenous injection of 0.5-1 ml/kg of 50% dextrose
water, and prevented by administering a 10% dextrose
infusion at 1-2 mg/kg per hour. The plasma glucose
should be maintained between 4-8 mmol/l (80-120
mg/dl) and checked frequently.
Haematological
Bleeding diathesis: Thrombocytopenia is common,
but platelet transfusion is indicated only if the patient
has systemic bleeding. Thrombocytopenia per se is
not an indication for platelet transfusion. Coagulation
abnormality leading to systemic bleeding is
uncommon. With sensitive measures, activation of the
coagulation cascade can be detected in all patients
with acute symptomatic malaria [9 J but significant
disseminated intravascular coagulation occurs in less
than 5% of patients with severe disease IS I. Hepatic
failure and prolonged prothrombin time is rare.
Transfusion of coagulation factors is only indicated in
patients with coagulation abnormality and systemic
bleeding.
Severe anaemia: Anaemia develops very rapidly and
blood transfusion is often required [10, I I J. Anaemia
results from a combination of bone marrow
suppression and accelerated red cell destruction [12-
14] of both parasitized and unparasitized red cells.
Blood transfusion is indicated inpatients with severe
anaemia. Blood should be cross-matched on
admission and transfused to maintain the haematocrit
over 21%. Transfusion rates should be slow to avoid
volume overload, and it may be necessary to give a
potent diuretic such as frusemide intravenously at
the same time.
Blackwater fever: Massive intravascular haemolysis
and haemoglobinuria can sometimes cause ARP. It
is usually seen in patients with glucose-6-phosphate
dehydrogenase deficiency [1SJ,
Metabolic acidosis
This condition is serious and rapidly fatal. Lactic
acidosis and renal impairment both contribute to
hydrogen ion retention. Lactic acidosis results from
the parasite. increased anaerobic glycolysis and a
failure of hepatic gluconeogenesis [16]. Sodium
bicarbonate (8.4%) may be given if arterial pH falls
below 7.1. The pyru vate dehydrogenase acti vator
dichloroacetate has proved promising in pilot
clinical trials and experimental studies 117-191.
Bacterial infections
Gram-negaf ve septicaemia [20 J, aspi ration
pneumonia and urinary tract infections may all
occur and should be treated with appropriate
antibiotics. Any patient who develops shock at any
stage should be investigated as in one report40% of
patients had positive blood cultures. ln our own
experience (unpublished) almost all shock patients
had negative blood culture and the causes of shock
were considered to be due to multiple organ failure.
severe metabolic acidosis, ARDS.
Endotoxemia originates from the gut, either by entry
of gram-negative bacteria or endotoxin from the gut
lumen [21,221. together with failure of normal
hepatic clearance mechanisms 1231.
Hepatic dvfunction
A cholestatle jaundice is common in severe malaria,
although hepatic failure is very rare. Haemolysis
also contributes to the hypcrbilirubinacrnia.
Hepatosplenomegaly is common and in Thailand
half of the adults and children over six years of age
with cerebral malaria have palpable liver or spleen.
Massive splenomegaly is most unusual in severe
malaria.
Pathogenesis
Numerous reports of examination of renal tissue by
light microscopy describe the non-specific features
of acute tubular necrosis, but there has been no
systematic investigation or the renal ultrastructural
changes seen by electron microscopy. Thus our
concept of pathological changes in the glomerular
and tubular microcirculation are derived from those
seen in the cerebral circulation.
Histology: In the brain, extensive plugging of cerebral
capillaries has been recognised for years. This is due
to margination (adhesion to endothelium) and
sludging (stasis and aggregation) of parasitised red
cells. Fibrin formation leading to thrombosis is not a
feature. In an electron microscopy study [24],
occasional neutrophils were seen, but other leucocytes
were not observed in significant numbers either inside
or outside of vessels. There was a total absence of
platelets. The endothelium frequently showed
degenerative changes on the surface, disorganisation
of cytoplasm, with pseudopodia sticking out from the
endothel ial surface.
ln the kidney, by light microscopy, dilated peri tubular
capillaries and interlobular veins are congested with
pigment-macrophages, parasitised red cells, young
lymphocytes and plasma cells. Occasional platelet-
fibrin thrombi are seen 125,26]. Tubular necrosis is
seen in most cases involving distal and collecting
tubules and rarely proximal convoluted tubules.
Necrotic tubules, both in the cortex and medulla.
contain granular haemoglobin casts [27]. The great
majority of parasitised red blood cells in the kidney
are in glomeruli and some are adherent to the
endothelium. Very few are seen elsewhere [241.
Outcome
Acute renal failure (ARF) is one of the three most
common causes of death in severe malaria [281. The
outcome depends on the time between onset of
symptoms and arrival to a health facility and on the
available facility resources and health worker capacity
to manage the complications. Most severely ill
patients live in rural areas endemic for malaria where
the facilities are limited.
Before 1980, the mortality rate of patients with severe
complicated malaria was 29 - 50% 129,301. Moreover,
in cases with lung complications, the mortality rate
rose to 60 - 75% 129,311. During the Vietnam war the
mortality from ARF fell from 50o/c to 15-20% once
dialysis facilities became available 1301. Since 1980,
with early dialysis for renal failure and full respiratory
support, the mortality rate of complicated malaria has
declined to 10 - 20%. In Vietnam the mortality of
ARF with malaria has fallen from 75% to 26% with
the introduction of peritoneal dialysis 1321.
In our own study of 122 patients with malarial acute
renal fai lure admitted lO the Bangkok Hospital for
Tropical Disease, during the period 1991-1997, 101
(90.2%) patients received hemodialysis 1331. Ninety-
three patients were oliguric and the remainder were
non-oliguric. The overall mortality was I I %. Of the
12 patients who died, I I were jaundiced and eight had
cerebral malaria.
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